Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06965803 · ClinicalTrials.gov registry record

This Study is to Evaluate Whether Receiving Education and Glucose Monitoring With the CGM Device Will Improve Patient-reported Outcomes by Improving Patient's Satisfaction and Quality of Life (QOL) With Glucose Monitoring Device

A clinical trial of Diabetes Mellitus, sponsored by Cedars-Sinai Medical Center.

Recruiting
Registry status
37
Enrollment target
1
Study location

NCT06965803 is a study of Diabetes Mellitus that is actively recruiting participants, run by Cedars-Sinai Medical Center. The registered enrollment target is 37 participants, below the 1,867-participant average among 208 other Diabetes Mellitus trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06965803, a study of Diabetes Mellitus, is actively recruiting participants, sponsored by Cedars-Sinai Medical Center.

RECRUITING
Registry status
37 participants
Enrollment target
1
Study location

Study Summary

The purpose of the study is to improve patient-reported outcomes by improving patient's satisfaction and quality of life (QOL) with glucose monitoring device through pre and post satisfaction survey of patient with diabetes.

Conditions Studied

Study Locations (1)

California

  • Cedars-Sina Medical Center - Los Angeles

Trial Details

FieldValue
Enrollment Target 37 participants
Start Date 2025-10-01
Est. Completion 2026-12-30

Sponsor

Cedars-Sinai Medical Center

339 total trials

What the Registry Record Tells You About NCT06965803

The ClinicalTrials.gov registry entry for NCT06965803 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 37 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,867-participant average among 208 other Diabetes Mellitus trials with a reported enrollment target (98% lower). The listed sponsor is Cedars-Sinai Medical Center, which has 339 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Diabetes Mellitus appearing as the primary indexed condition, and to 0 interventions.

NCT06965803 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT06965803 about?

NCT06965803 is a clinical study titled "This Study is to Evaluate Whether Receiving Education and Glucose Monitoring With the CGM Device Will Improve Patient-reported Outcomes by Improving Patient's Satisfaction and Quality of Life (QOL) With Glucose Monitoring Device". The purpose of the study is to improve patient-reported outcomes by improving patient's satisfaction and quality of life (QOL) with glucose monitoring device through pre and post satisfaction survey of patient with diabetes.

What is the current status of trial NCT06965803?

This trial is currently recruiting. The enrollment target is 37 participants. The study started on 2025-10-01. Estimated completion is 2026-12-30.

What conditions does trial NCT06965803 study?

This clinical trial studies the following conditions: Diabetes Mellitus.

Who is sponsoring clinical trial NCT06965803?

This trial is sponsored by Cedars-Sinai Medical Center, which has 339 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06965803 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Diabetes Mellitus

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.